New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity and cardiovascular and ...
May 20, 2025
0
0
A new study published in Science Advances reveals that a single gene plays a big role in how the liver stores energy, a process that's critical for overall health and for managing diseases like type 2 diabetes. Led by Penn ...
May 18, 2025
0
98
Irritable bowel syndrome (IBS) is a prevalent and debilitating gastrointestinal disorder affecting approximately 5%–10% of the global population. Characterized by abdominal pain, bloating, and altered bowel habits, IBS ...
May 16, 2025
0
41
Approximately 30% of the global population is affected by metabolic-associated fatty liver disease (MASLD), a condition that previously lacked targeted treatments. Researchers have now identified a genetic factor that exacerbates ...
May 16, 2025
0
62
A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the ...
May 13, 2025
0
65
Women who experience menopause before the age of 50—and especially before the age of 45—are more likely to develop fatty liver disease and its related metabolic risk factors within one year after menopause, according ...
May 10, 2025
0
0
Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth prematurely and the risk increase cannot be explained by obesity, according to a new study from Karolinska ...
May 9, 2025
0
0
Researchers at Peking University have discovered that a filamentous gut fungus, Fusarium foetens, can reverse metabolic dysfunction–associated steatohepatitis (MASH) in mice. These findings have implications for developing ...
The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found.
May 1, 2025
0
0
Results from the ESSENCE Phase III clinical trial published in the New England Journal of Medicine show treating patients with semaglutide can halt and even reverse liver disease.
Apr 30, 2025
0
210
